| Altheos Accepts First Venture Capital Funding |
|
|
| Wednesday, April 07, 2010 5:39:00 AM PDT | VentureDeal Staff |
San Francisco, California -- Pharmaceutical development company Altheos has secured $20 million for its series A round of institutional venture capital investment.
Altheos is developing topical treatments for glaucoma and says that the financing proceeds will be used for the development of its lead candidate, ATS907.
Bay City Capital led the round, which also included Novo A/S, Caanan Partners and other investors. |
|
|
 Email Page |  Print Page |
|
|
|
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
|
 |
|
|
|
 |